Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
RA
ReproNovo ApS
aktivCVR 44291908AnpartsselskabAmagerfælledvej 106, 2300 København SFremstilling af farmaceutiske præparater
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 23 Sept 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK 2.7m
Latest period
Source details
Source: dk-regnskabsdata-live-44291908-1790153783366
Document: dk-regnskabsdata-44291908-AZ8cz44kcguJTV-xHIQW-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u3
Net result
DKK 1.5m
Latest period
Source details
Source: dk-regnskabsdata-live-44291908-1790153783366
Document: dk-regnskabsdata-44291908-AZ8cz44kcguJTV-xHIQW-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u3
Equity
DKK 2.8m
Equity ratio: 16%
Source details
Source: dk-regnskabsdata-live-44291908-1790153783366
Document: dk-regnskabsdata-44291908-AZ8cz44kcguJTV-xHIQW-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c49
Unit: u3
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | — |
| 2024 | DKK 32.4m | DKK 1.2m |
| 2025 | — | DKK 1.5m |